Related Experiment Video
Updated: May 20, 2026

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Published on: January 19, 2019
Epilepsy in Epidermal Nevus Syndromes: Review.
Odette El Ghawi1,2, Praveen Kumar Ramani3
1Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon.
Epidermal nevus syndromes (ENS) often cause epilepsy, a frequent complication. This review details neurologic manifestations, focusing on epilepsy subtypes, brain anomalies, and management strategies in ENS patients.
Area of Science:
- Neurocutaneous syndromes
- Dermatology
- Neurology
Background:
- Epidermal nevus syndromes (ENS) are a diverse group of neurocutaneous disorders characterized by epidermal hamartomas and extracutaneous manifestations.
- Epilepsy is a common and disabling complication of ENS, yet the genotype-phenotype correlation remains unclear.
Purpose of the Study:
- To provide a comprehensive overview of the neurologic manifestations of ENS, with a specific focus on epilepsy.
- To systematically analyze the epileptogenic potential across 10 well-defined ENS subtypes.
Main Methods:
- Systematic review of the literature on neurologic manifestations and epilepsy in ENS.
- Detailed examination of seizure types, EEG findings, and associated brain anomalies (e.g., hemimegalencephaly, cortical dysplasia).
- Focus on high-seizure burden subtypes: keratinocytic epidermal nevus syndrome, nevus sebaceus syndrome, phakomatosis pigmentokeratotica, nevus comedonicus syndrome, and angora hair nevus syndrome.
Main Results:
- ENS subtypes exhibit distinct seizure characteristics, EEG patterns, and neuroimaging findings.
- Specific ENS subtypes, including keratinocytic epidermal nevus syndrome and nevus sebaceus syndrome, are associated with a high epilepsy burden.
- Common structural brain anomalies include hemimegalencephaly, cortical dysplasia, and neuronal heterotopias.
Conclusions:
- Early diagnosis and multidisciplinary management are crucial for optimizing seizure control and neurologic outcomes in patients with ENS.
- Understanding the relationship between genotype, cutaneous phenotype, and seizure phenotype is essential for targeted therapies.
- Current management includes medical, surgical, and emerging molecular targeted therapies for epilepsy in ENS.
Related Concept Videos
Epilepsy ll: Types
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

